(Allergan plc)

	AGN latest price $212.2781 (-2.18%) ($210.6760 - $218.1270) on Tue. Apr. 26, 2016.
	Trend Analysis and Forecast
Average Daily Percentage Swing	2.64% (three month average)
RSI	25
Latest Price	$212.2781(-2.18%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN declines -0.5% a day on average for past five trading days.
Weekly Trend	AGN declines -1.6% a week on average for past two weeks.
Market Behavior	Value stock rally for large cap. Broad based rally for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(53%)    XLV(51%)    XBI(47%)    ARKG(43%)    SPY(42%)
Factors Impacting AGN price	AGN will decline at least -1.32% in a week (0% probabilities).   VIXM(-29%)    TLT(-16%)    UUP(-13%)    IBUY(-6%)    SHY(-4%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-1.32% (StdDev 2.64%)
Hourly BBV	0 ()
Intraday Trend	-2.3%

Resistance Level	$227.15
5 Day Moving Average	$218(-2.62%)
10 Day Moving Average	$215.27(-1.39%)
20 Day Moving Average	$227.15(-6.55%)
To recent high	-26.4%
To recent low	1.6%
Market Cap	$69.988b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed